Case Studies in HIV Prevention Among Communities at High Risk for HIV
Release Date: December 23, 2022
Support for this activity has been made possible through educational grants from Gilead Sciences, Merck, Theratechnologies, and ViiV Healthcare.
Access to HIV prevention, including preexposure prophylaxis (PrEP) continues to improve. Despite this progress, PrEP access remains unevenly distributed among race and gender. Preliminary CDC data show only 9% (42,372) of the nearly 469,000 Black people who could benefit from PrEP received a prescription in 2020. While cis gender women make up almost 25% of people living with HIV in the US and excess risk of cardiovascular and cerebrovascular events in individuals with HIV are amplified in women, PrEP coverage was also about three times less in 2020 among cis gender women (10%) as compared to males (28%). In order to reduce new HIV infections in the U.S. by 90% by 2030, scaling up HIV prevention and treatment strategies in these populations will be critically important.
Using a combination of didactic presentation and case vignettes, this free interactive CME/CNE-certified webinar will aim to discuss and propose how multidisciplinary teams can implement solutions to overcome HIV prevention barriers faced by these populations.
- Identify potential missed opportunities to introduce HIV prevention among Black individuals and among cis gender women
- List the key components of effective sexual health history taking technique
- Create a workflow with your care team to engage patients in HIV prevention efforts and retain them in care
Minh Q. Ho, MD
Infectious Disease Physician
Orlando VA Healthcare System
Karen Slazinski, PharmD, BCPS, AAHIVP
Clinical Pharmacy Practitioner, Infectious Disease
Orlando VA Healthcare System
VHA’s HHRC National PrEP QI Pharmacy Lead
Minh Q. Ho, MD, is an infectious disease physician with experience in adult medicine, infectious disease and public health. He has been with Orlando VA Healthcare System (OVAHCS) since 2016 as a clinical hospital epidemiologist. He also works closely with medical students and residents in his role as a faculty with University of Central Florida Department of Medicine. Dr. Ho also plays an active role as site investigator for several funded research from VA Office of Research and Development and National Heart, Lung, and Blood Institute (NHLBI). In his clinical role, he practices general infectious disease with emphasis on HIV, Preexposure Prophylaxis and persons who inject drugs. He helped to create and currently leads RIS4E, a harm reduction program with emphasis on providing sterile syringes, STI/HIV testing, naloxone as well as connecting veterans to other VA services such as mental health.
Karen Slazinski, PharmD, BCPS, AAHIVP, has been an outpatient ID pharmacist at the Orlando VA Medical Center for the past 20 years. She received her PharmD degree from the University of Florida, then completed a Pharmacy Residency at the Gainesville, Florida VA. There she continued as the inpatient infectious disease pharmacist for 6 years. She was ACCP board certified in Pharmacotherapy in 1995 and ASCP board certified in Geriatrics in 1997 and has been credentialed by the American Academy of HIV Medicine since 2008. At the Orlando VA Medical Center, she focuses on PrEP, HIV and hepatitis. For the past 2 years she has acted as the HHRC National PrEP QI Pharmacy Lead.
Accreditation and Credit Designation
In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses
American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours.(0.8 Pharmacotherapeutic Contact Hours)
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until December 23, 2023. PAs should only claim credit commensurate with the extent of their participation.
Other members of the care team will receive a certificate of participation.
This activity has been designed to meet the educational needs of the HIV care team, including physicians (both specialists and primary care/family medicine), nurses, nurse practitioners, physician assistants, and pharmacists who are in practice but are newer to HIV medicine or who are in training. Other healthcare providers may also participate.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Disclosure of relevant financial relationships are as follows:
Minh Q. Ho, MD: No relevant financial relationships to disclose.
Karen Slazinski, PharmD, BCPS, AAHIVP: No relevant financial relationships to disclose.
John JD Juchniewicz, MCIS, CHCP, FACEHP; Natalie Kirkwood, RN, BSN, JD; Edward Moylan RP; Daiquiri Y. Robinson: No relevant financial relationships to disclose.
This activity will not review off-label or investigational information.
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or its ACTHIV Institute. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Instructions on How to Receive Credit
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CE credit for your participation, please complete the post-assessment and program evaluation. Your certificate will be available for printing immediately.
Privacy and Contact
This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended.
© 2022. This accredited continuing education activity is held as copyrighted © by American Academy of CME. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).